Latest MS research news

Latest MS research news | 27 August 2013

L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients

This study looked at identifying people at risk of developing progressive multifocal leucoencephalopathy (PML) during natalizumab treatment.

From MSIF

Latest MS research news | 27 August 2013

Surgical outcomes of trigeminal neuralgia in patients with multiple sclerosis

In this study from the US, the researchers looked at the surgical interventions for the treatment of MS-related trigeminal neuralgia (TN) compared with classic TN by evaluating initial pain-free response (IPFR), duration of pain-free intervals (PFI) and factors ...

From MSIF

Latest MS research news | 13 August 2013

Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration

This study from Italy investigated the synaptic mechanism of inflammatory neurodegeneration in progressive forms of MS.

From MSIF

Latest MS research news | 13 August 2013

Topography of brain sodium accumulation in progressive multiple sclerosis

In this study from France, the researchers looked at sodium accumulation in people with progressive MS on a 3T MR scanner in 11 PPMS, 9 SPMS and 15 controls.

From MSIF

Latest MS research news | 13 August 2013

Prevalence of radiologically isolated syndrome and white matter signal abnormalities in healthy relatives of MS patients

This study compared white matter signal abnormality characteristics and the prevalence of radiologically isolated syndrome (RIS) in healthy subjects selected randomly from the population ...

From MSIF

Latest MS research news | 06 August 2013

Retinal periphlebitis is associated with multiple sclerosis severity

This study assessed the association between primary retinal inflammation (retinal periphlebitis (RP)) and microcytic macular edema (MME)) and clinical (EDSS) and imaging (brain and retinal) biomarkers of disease severity to evaluate their suitability ...

From MSIF

Latest MS research news | 06 August 2013

Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk

This study looked at the association between MS risk and anti-Epstein-Barr virus (EBV)-specific antibody levels in addition to HLA-DR profiles, gender and age in a population-based cohort involving 426 people with MS ...

From MSIF

Latest MS research news | 06 August 2013

Association between multiple sclerosis risk-associated SNPs and relapse and disability - a prospective cohort study

This study from Australia investigated if known MS risk-associated single-nucleotide polymorphisms (SNPs) were associated with clinical course and if these SNPs modified the 25(OH)D-relapse association.

From MSIF

Latest MS research news | 30 July 2013

Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS

This study looked at the different types of cortical lesions at ultra-high field MRI and their contribution to neurological disability and cognitive performance in 34 people with RRMS, SPMS and clinically isolated syndrome.

From MSIF

Latest MS research news | 30 July 2013

Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis

This study from Australia looks at the interaction between genes and environmental factors on the clinical course of MS.

From MSIF
 

Latest MS research news

Main MS research areas

Challenges of MS research

Atacicept in multiple sclerosis: a randomised, placebo-controlled, double-blind, phase 2 trial